Ligand Pharmaceuticals Incorporated Tangible Net Worth Ratio
Ligand Pharmaceuticals Incorporated tangible net worth ratio. Ligand Pharmaceuticals Incorporated (LGND) has a Tangible Net Worth Ratio of 78.4% as of June 2026. This metric is calculated by deducting intangible assets ($209.24 Million) from net assets ($967.52 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Ligand Pharmaceuticals Incorporated annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Ligand Pharmaceuticals Incorporated (1994–2025)
Tangible net worth ratio of Ligand Pharmaceuticals Incorporated from 1994 to 2025. This chart shows how Ligand Pharmaceuticals Incorporated's Tangible Net Worth Ratio has changed across 24 annual periods from 1994 to 2025. As of June 2026, the ratio stands at 78.4%, reflecting net assets of $967.52 Million with intangible assets of $209.24 Million USD. Check Ligand Pharmaceuticals Incorporated strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Ligand Pharmaceuticals Incorporated Tangible Net Worth Ratio by Year (1994–2025)
Ligand Pharmaceuticals Incorporated tangible net worth ratio by year from 1994 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Ligand Pharmaceuticals Incorporated from 1994 to 2025, covering 24 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Ligand Pharmaceuticals Incorporated.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 58.5% | $1.02 Billion | $422.31 Million | $1.56 Billion | ▼ -9.4 pp |
| 2024 | 67.9% | $830.44 Million | $266.65 Million | $941.77 Million | ▲ +10.6 pp |
| 2023 | 57.3% | $700.91 Million | $299.61 Million | $787.22 Million | ▲ +16.3 pp |
| 2022 | 41.0% | $597.49 Million | $352.64 Million | $762.67 Million | ▼ -11.9 pp |
| 2021 | 52.9% | $821.16 Million | $386.80 Million | $1.30 Billion | ▲ +38.3 pp |
| 2020 | 14.5% | $709.52 Million | $606.31 Million | $1.36 Billion | ▼ -55.4 pp |
| 2019 | 70.0% | $767.23 Million | $230.54 Million | $1.49 Billion | ▼ -24.4 pp |
| 2018 | 94.4% | $560.91 Million | $31.46 Million | $1.26 Billion | ▼ -0.9 pp |
| 2017 | 95.3% | $418.65 Million | $19.53 Million | $671.02 Million | ▲ +2.3 pp |
| 2016 | 93.0% | $370.85 Million | $25.82 Million | $601.59 Million | ▼ -4.2 pp |
| 2015 | 97.2% | $304.39 Million | $8.55 Million | $533.93 Million | ▲ +15.9 pp |
| 2014 | 81.3% | $24.41 Million | $4.57 Million | $258.03 Million | ▼ -9.5 pp |
| 2013 | 90.8% | $49.61 Million | $4.57 Million | $104.71 Million | ▲ +201.9 pp |
| 2012 | -111.1% | $26.48 Million | $55.91 Million | $104.26 Million | ▲ +453.2 pp |
| 2011 | -564.3% | $8.65 Million | $57.44 Million | $122.35 Million | ▼ -597.1 pp |
| 2009 | 32.8% | $3.74 Million | $2.52 Million | $113.70 Million | ▼ -67.2 pp |
| 2007 | 100.0% | $29.11 Million | $0.00 | $173.28 Million | ▲ +303.8 pp |
| 2006 | -203.8% | $27.35 Million | $83.08 Million | $326.05 Million | ▼ -108.8 pp |
| 2003 | -94.9% | $70.73 Million | $137.86 Million | $301.25 Million | ▲ +5.8 pp |
| 2002 | -100.7% | $74.02 Million | $148.55 Million | $270.61 Million | ▼ -200.7 pp |
| 1997 | 100.0% | $34.30 Million | $0.00 | $107.40 Million | ▲ +0.0 pp |
| 1996 | 100.0% | $34.50 Million | $0.00 | $102.10 Million | ▲ +0.0 pp |
| 1995 | 100.0% | $28.10 Million | $0.00 | $93.60 Million | ▲ +0.0 pp |
| 1994 | 100.0% | $26.30 Million | $0.00 | $46.70 Million | — |